News Conference News ACC 2024 Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC Michael O'Riordan April 08, 2024
News Conference News TCT 2023 Intermittent Coronary Sinus Occlusion Fails to Cut Infarct Size in STEMI Yael L. Maxwell November 06, 2023
News Conference News TCT 2023 Does Thrombolysis Have a Role in a Primary-PCI World? Experts Hash It Out Michael O'Riordan October 25, 2023
News Daily News FDA: Class I Recall for Left-Sided Impella Pumps Due to TAVI Interaction Caitlin E. Cox July 27, 2023
News Daily News PA Catheters in Cardiogenic Shock: Patchy Usage, Potential Gains Shelley Wood June 22, 2023
News Daily News Medicare Data on AMICS Too Muddied for Firm Conclusions on Impella Caitlin E. Cox June 21, 2023
News Daily News Modifying Antiplatelet Therapy: ARC Consensus Aims to Standardize Definitions Todd Neale June 20, 2023
News Daily News Abiomed Recalls Certain Impella 5.5 Devices Due to Risk of Purge-Fluid Leaks Caitlin E. Cox June 05, 2023
News Conference News ACC 2023 Short DAPT Noninferior to 1 Year After Ultrathin DES PCI: HOST-IDEA Yael L. Maxwell March 09, 2023
News Daily News For TAVI Patients With CAD, Lifetime Management Is Key: EAPCI Michael O'Riordan February 23, 2023
News Conference News AHA 2022 Early ECMO No Better Than Watch-and-Wait Approach in Cardiogenic Shock Caitlin E. Cox November 06, 2022
News Daily News Longer-Term Data Still Worrisome for Impella-Treated AMICS Patients Caitlin E. Cox July 20, 2022
News Daily News Early Redo TAVI Outcomes Look Good, but ‘Far From Definitive’ Michael O'Riordan July 18, 2022
News Conference News EuroPCR 2022 Long-term Outcomes With PCI and CABG: More Analyses to Stir the Pot Michael O'Riordan May 23, 2022
News Daily News Texting Tool Failed to Up Pill Adherence in ACS Patients: TEXTMEDS Caitlin E. Cox May 10, 2022
News Conference News ACC 2022 BIO|GUARD-MI: Post-MI Arrhythmia Monitoring Falls Short Todd Neale April 11, 2022
News Conference News ACC 2022 Nitroglycerin Given Early or Late Fails to Prevent Radial Artery Occlusion: PATENS Michael O'Riordan March 25, 2022